LUNG Stock Analysis: Buy, Sell, or Hold?
LUNG - Pulmonx Corporation Common Stock
$2.26
-0.04 (-1.74%)
âŧ
5d:
-6.61%
30d:
+85.25%
90d:
+46.75%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Jul 29, 2026
0d
Get Alerted When LUNG Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: LUNG is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: LUNG is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: LUNG is currently trading at $2.26, which is considered slightly high relative to its 30-day fair value range of $1.37 to $2.27.
Technical Outlook: Technically, LUNG is in a uptrend. Immediate support is located at $2.03, while resistance sits at $2.48.
Market Sentiment: LUNG scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Implied Volatility is high (72th percentile), indicating expensive options premiums. This environment often favors selling options or covered calls to generate income. Wall Street analysts see significant upside, with an average price target of $3.40 (+50.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, LUNG is in a uptrend. Immediate support is located at $2.03, while resistance sits at $2.48.
Market Sentiment: LUNG scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Implied Volatility is high (72th percentile), indicating expensive options premiums. This environment often favors selling options or covered calls to generate income. Wall Street analysts see significant upside, with an average price target of $3.40 (+50.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$1.37 -
$2.27
Company Quality Score
35/100
(SELL)
Options IV Signal
72th percentile
(EVENT RISK)
Volume Confirmation
HIGH
Confidence Score
33.3%
All Signals
- BEARISH: Options expensive (IV 72th percentile)
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 50.4% below Wall St target ($3.40)
- WARNING: Composite score 35/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.37 -
$2.27
Current vs Trading Range
SLIGHTLY HIGH
Expected Move (7 Days)
Âą$0.58
(25.5%)
Support & Resistance Levels
Support Level
$2.03
Resistance Level
$2.49
Current Trend
Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.40
Wall Street Target
$3.40
(+50.4%)
Revenue Growth (YoY)
-4.6%
Profit Margin
-55.0%
Share & Embed Analysis
Last updated: August 24, 2026 12:08 AM ET
Data refreshes hourly during market hours. Next update: 1:08 AM
Data refreshes hourly during market hours. Next update: 1:08 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LUNG showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Geoffrey Beran Rose
SELL
7732 shares
2026-03-02
Glendon E French III
SELL
67813 shares
2026-03-02
Srikanth Radhakrishnan
SELL
10483 shares
2026-03-02
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$63 | 49 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$383 | 53 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 48 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 31 SELL |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$120 | 37 SELL |
